NASDAQ: MDWD - MediWound Ltd.

Lønnsomhet i seks måneder: +13.75%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan MediWound Ltd.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet MediWound Ltd.

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.

flere detaljer
The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2014-03-20
ISIN IL0011316309
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.mediwound.com
Цена ао 15.56
Prisendring per dag: -0.7291% (17.83)
Prisendring per uke: +7.34% (16.49)
Prisendring per måned: +1.43% (17.45)
Prisendring over 3 måneder: +0.7399% (17.57)
Prisendring over seks måneder: +13.75% (15.56)
Prisendring per år: +74.04% (10.17)
Prisendring over 3 år: +653.19% (2.35)
Prisendring over 5 år: +491.97% (2.99)
Prisendring over 10 år: 0% (17.7)
Prisendring siden begynnelsen av året: +7.4% (16.48)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 4.96 3
P/BV 2.36 6
P/E 0 0
EV/EBITDA -6.15 0
Total: 4.63

Effektivitet

Navn Betydning Karakter
ROA, % -10.11 0
ROE, % -21.26 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.4727 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % -41.24 0
Lønnsomhet Ebitda, % -187.38 0
Lønnsomhet EPS, % -177.81 0
Total: 0
Flere detaljer

Institusjoner Volum Dele, %
Point72 Asset Management, L.P. 821500 6.44
Rosalind Advisors, Inc. 606751 4.76
DAFNA Capital Management, LLC 257653 2.02
Uniplan Investment Counsel, Inc. 145270 1.14
Wells Fargo & Company 132104 1.04
Yelin Lapidot Holdings Management Ltd. 125493 0.98
Sargent Investment Group, LLC 109194 0.86
Silverberg Bernstein Capital Management LLC 85184 0.67
Renaissance Technologies, LLC 55944 0.44
Sphera Funds Management Ltd. 48980 0.38

ETF Dele, % Lønnsomhet for året, % Utbytte, %
ARK Israel Innovative Technology ETF 1.84994 24.64 1.21688
Vanguard Russell 2000 Growth ETF 0.01 23.05 0.60264
Vanguard Russell 2000 ETF 0.01 17.16 1.48801
ProShares UltraPro Russell2000 0.00304 89.82 1.47873
ProShares Hedge Replication ETF 0.00087 5.92 1.47892
Vanguard Russell 3000 ETF 0 31.87 1.43817



Veileder Stillingstittel Betaling Fødselsår
Mr. Ofer Gonen B.Sc. Chief Executive Officer 649k 1973 (52 år)
Dr. Lior Rosenberg M.D. Co-Founder 727k 1946 (79 år)
Dr. Ety Klinger MBA, Ph.D. Chief Research & Development Officer 377k 1962 (63 år)
Ms. Hani Luxenburg Chief Financial Officer 235k 1973 (52 år)
Dr. Shmulik Hess Ph.D. COO & Chief Commercial Officer N/A 1973 (52 år)
Mr. Yaron Meyer Adv. Executive VP, General Counsel & Corporate Secretary 299k 1979 (46 år)
Mr. Barry J. Wolfenson Executive Vice President of Strategy & Corporate Development N/A 1967 (58 år)
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc. Chief Medical Officer N/A 1950 (75 år)
Dr. Liron Gal Executive Director of Manufacturing Science & Technology

Adresse: Israel, Yavne, 42 Hayarkon Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.mediwound.com